Hipromine (WAR:HPM) Stock Based Compensation: zł0.00 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:HPM Hipromine SA WAR:HPM
53 GF Score
Price zł77.00
GF Value zł859.28
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Hipromine Stock Based Compensation?

Hipromine WAR:HPM -2.53% 53 Stock Based Compensation is zł0.00 Mil as of Mar. 2026. GuruFocus rates WAR:HPM with a GF Score™ of 53/100 and a GF Value™ of zł859.28 (Possible Value Trap). The stock has 7 warning signs investors should review.

Hipromine's Stock Based Compensation for the three months ended in Mar. 2026 was zł0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was zł0.00 Mil.


Hipromine Stock Based Compensation Related Terms


Hipromine Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Hipromine's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hipromine Stock Based Compensation Chart

Hipromine Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Hipromine Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WAR:HPM
53GF Score
Hipromine SA WAR:HPM
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hipromine Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.00 Mil.

What does a Stock Based Compensation of zł0.00 Mil mean?
Hipromine (WAR:HPM) has a Stock Based Compensation of zł0.00 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Hipromine and its competitors.
Is Hipromine's Stock Based Compensation too high?
Hipromine's current Stock Based Compensation is zł0.00 Mil. Overall, Hipromine has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hipromine's Stock Based Compensation compare to KHC and GIS?
Hipromine's Stock Based Compensation of zł0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Consumer Packaged Goods company?
A good Stock Based Compensation depends on the Consumer Packaged Goods industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Hipromine and its competitors. Hipromine's current Stock Based Compensation is zł0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hipromine stock overvalued right now?
Based on GuruFocus' analysis, Hipromine (WAR:HPM) is currently considered Possible Value Trap. The stock's GF Value™ is zł859.28, compared to a current price of zł77.00 — trading 91% below its estimated fair value. The current Stock Based Compensation is zł0.00 Mil. Hipromine's overall GF Score™ is 53/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Hipromine (WAR:HPM), the current Stock Based Compensation is zł0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hipromine (WAR:HPM) Overvalued in 2026?

Based on GuruFocus' analysis, Hipromine stock appears to be undervalued. The current stock price of zł77.00 is trading 91% below its estimated GF Value™ of zł859.28. GuruFocus considers Hipromine to be Possible Value Trap.

Key valuation signals for WAR:HPM:

  • Stock Based Compensation: zł0.00 Mil
  • GF Value™: zł859.28 vs. price of zł77.00 (91% below fair value)
  • GF Score™: 53/100 with 7 warning signs

No single metric tells the full story. See the WAR:HPM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hipromine Business Description

Address ul. Poznańska, 12th Floor, Robakowo, POL, 62-023
Hipromine SA is a European scale supplier of an alternative protein produced through innovative, proprietary technology of industrial insect breeding. The company's offer is directed mainly to the market of pet food and fodder for fish farming, as well as livestock and horticulture.
53GF Score

Get the complete analysis for WAR:HPM

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł77.00
Price
zł859.28
GF Value